연구성과로 돌아가기

2021 연구자 정보 (31 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Yan, Victoria C.
(Yan, VC)
Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA HGU-5980-2022
Cyan, Victoria
0000-0003-0837-5184
Yan, Victoria
[JCR상위 1.7] NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis SCIE 1.7 CELL BIOLOGY;ENDOCRINOLOGY & METABOLISM yoonje@musc.edu;msong1@mdanderson.org;
Yao, Yixin
(Yao, YX)
Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
0000-0002-8439-6043
Yao, Yixin
[JCR상위 1.7] NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis SCIE 1.7 CELL BIOLOGY;ENDOCRINOLOGY & METABOLISM yoonje@musc.edu;msong1@mdanderson.org;
Yeh, Chih-Chen
(Yeh, CC)
Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA KRO-7149-2024
CHEN, YUFEI

[JCR상위 1.7] NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis SCIE 1.7 CELL BIOLOGY;ENDOCRINOLOGY & METABOLISM yoonje@musc.edu;msong1@mdanderson.org;
Yoon, Je-Hyun
(Yoon, JH)
교신저자 Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA
0000-0001-7615-8654
Yoon, Je-Hyun
[JCR상위 1.7] NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis SCIE 1.7 CELL BIOLOGY;ENDOCRINOLOGY & METABOLISM yoonje@musc.edu;msong1@mdanderson.org;
Zhang, Li
(Zhang, L)
Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA

[JCR상위 1.7] NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis SCIE 1.7 CELL BIOLOGY;ENDOCRINOLOGY & METABOLISM yoonje@musc.edu;msong1@mdanderson.org;
Awais, Ahmad Ali
(Awais, AA)
Kyungpook Natl Univ, Sch Mech Engn, Daegu 41566, South Korea
Pusan Natl Univ, Sch Mech Engn, Busan 46241, South Korea

0009-0004-3353-4997
0000-0003-3943-1425
Awais, Ahmad Ali
[JCR상위 1.8] CFD aided design and analysis of a precooler with zigzag channels for supercritical CO2 power cycle
[JCR상위 10.5] Performance enhancement in minichannel heat sinks using supercritical carbon dioxide (sCO2) as a coolant
SCIE 1.8 ENERGY & FUELS;MECHANICS;THERMODYNAMICS
ENGINEERING, MECHANICAL;MECHANICS;THERMODYNAMICS
muhammed.saeed1@ku.ac.ae;
manhoe.kim@knu.ac.kr;
Bae, Y.
(Bae, Y)
Asan Med Ctr, Asan Inst Life Sci, Hlth Innovat Bigdata Ctr, Seoul, South Korea

[JCR상위 1.8] eAssociation between nonalcoholic fatty liver disease and the incidence of asthma in adults: results from the korean national health insurance service-national sample cohort (NHIS-NSC) database SCIE 1.8 ALLERGY;IMMUNOLOGY
Berrouk, Abdallah S.
(Berrouk, AS)
Khalifa Univ Sci & Technol, Mech Engn Dept, POB 127788, Abu Dhabi, U Arab Emirates
Khalifa Univ Sci & Technol, Ctr Catalysis & Separat CeCas, POB 127788, Abu Dhabi, U Arab Emirates


[JCR상위 1.8] CFD aided design and analysis of a precooler with zigzag channels for supercritical CO2 power cycle SCIE 1.8 ENERGY & FUELS;MECHANICS;THERMODYNAMICS muhammed.saeed1@ku.ac.ae;
Cho, S.
(Cho, S)
Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea

[JCR상위 1.8] The clinical burden in systemic corticosteroid-independent asthmatics with high blood eosinophil counts: COREA cohort in Korea SCIE 1.8 ALLERGY;IMMUNOLOGY
Choi, Sae Won
(Choi, SW)
Seoul Natl Univ Hosp, Off Hosp Informat, Seoul, South Korea

[JCR상위 1.8] Characterization of asthma and risk factors for delayed SARS-CoV-2 clearance in adult COVID-19 inpatients in Daegu SCIE 1.8 ALLERGY;IMMUNOLOGY jhj0619@yu.ac.kr;haan33@gmail.com;
Daoud, H.
(Daoud, H)
Boehringer Ingelheim Int GmbH, Clin Trials, Ingelheim, Germany
Boehringer Ingelheim Int Gmbh, Ingelheim, Germany


[JCR상위 1.8] Sequential afatinib (afa) and osimertinib (osi) in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) NSCLC who acquire the T790M resistance mutation: A non-interventional cohort study (UpSwinG)
[JCR상위 5.1] Sequential Afatinib and Osimertinib in Patients With Advanced EGFRm plus NSCLC and Acquired T790M: The Real-World UpSwinG study
SCIE 1.8 ONCOLOGY
ONCOLOGY;RESPIRATORY SYSTEM
Escriu, C.
(Escriu, C)
Clatterbridge Canc Ctr, Thorac Med Oncol, Bebington, Wirral, Merseyside, England
Clatterbridge Canc Ctr, Wirral, Merseyside, England


[JCR상위 1.8] Sequential afatinib (afa) and osimertinib (osi) in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) NSCLC who acquire the T790M resistance mutation: A non-interventional cohort study (UpSwinG)
[JCR상위 5.1] Sequential Afatinib and Osimertinib in Patients With Advanced EGFRm plus NSCLC and Acquired T790M: The Real-World UpSwinG study
SCIE 1.8 ONCOLOGY
ONCOLOGY;RESPIRATORY SYSTEM
Girard, N.
(Girard, N)
Inst Curie, Inst Thorax Curie Montsouris, Thorac Surg, Paris, France
Inst Thorax Curie Montsouris, Inst Curie, Thorac Surg, Paris, France


[JCR상위 1.8] Sequential afatinib (afa) and osimertinib (osi) in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) NSCLC who acquire the T790M resistance mutation: A non-interventional cohort study (UpSwinG)
[JCR상위 5.1] Sequential Afatinib and Osimertinib in Patients With Advanced EGFRm plus NSCLC and Acquired T790M: The Real-World UpSwinG study
SCIE 1.8 ONCOLOGY
ONCOLOGY;RESPIRATORY SYSTEM
Hochmair, M. J.
(Hochmair, MJ)
Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Vienna, Austria

[JCR상위 1.8] Sequential afatinib (afa) and osimertinib (osi) in patients (pts) with advanced EGFR mutation-positive (EGFRm plus ) NSCLC who acquire the T790M resistance mutation: A non-interventional cohort study (UpSwinG)
[JCR상위 5.1] Sequential Afatinib and Osimertinib in Patients With Advanced EGFRm plus NSCLC and Acquired T790M: The Real-World UpSwinG study
SCIE 1.8 ONCOLOGY
ONCOLOGY;RESPIRATORY SYSTEM
Jin, H. J.
(Jin, HJ)
Yeungnam Univ, Dept Internal Med, Coll Med, Daegu, South Korea MHR-8031-2025
Jin, Hyunjung

[JCR상위 1.8] The clinical burden in systemic corticosteroid-independent asthmatics with high blood eosinophil counts: COREA cohort in Korea SCIE 1.8 ALLERGY;IMMUNOLOGY
페이지 이동: